Lagoda Investment Management LP Decreased Its Holding in T2 Biosystems INC (TTOO) as Share Price Rose

June 17, 2018 - By Richard Conner

T2 Biosystems, Inc. (NASDAQ:TTOO) Logo

Lagoda Investment Management Lp decreased its stake in T2 Biosystems Inc (TTOO) by 34.42% based on its latest 2018Q1 regulatory filing with the SEC. Lagoda Investment Management Lp sold 935,542 shares as the company’s stock rose 98.88% while stock markets declined. The institutional investor held 1.78 million shares of the health care company at the end of 2018Q1, valued at $11.57M, down from 2.72 million at the end of the previous reported quarter. Lagoda Investment Management Lp who had been investing in T2 Biosystems Inc for a number of months, seems to be less bullish one the $403.51M market cap company. The stock increased 1.48% or $0.14 during the last trading session, reaching $9.58. About 758,349 shares traded or 26.30% up from the average. T2 Biosystems, Inc. (NASDAQ:TTOO) has risen 181.59% since June 17, 2017 and is uptrending. It has outperformed by 169.02% the S&P500.

Lagoda Investment Management Lp, which manages about $725.00M and $264.97 million US Long portfolio, upped its stake in Berkshire Hathaway Inc Del (BRKB) by 27,794 shares to 29,929 shares, valued at $5.97 million in 2018Q1, according to the filing.

Analysts await T2 Biosystems, Inc. (NASDAQ:TTOO) to report earnings on August, 2. They expect $-0.34 earnings per share, up 32.00 % or $0.16 from last year’s $-0.5 per share. After $-0.36 actual earnings per share reported by T2 Biosystems, Inc. for the previous quarter, Wall Street now forecasts -5.56 % EPS growth.

More notable recent T2 Biosystems, Inc. (NASDAQ:TTOO) news were published by: Seekingalpha.com which released: “T2 Biosystems: Still A Buy After The Rally” on June 15, 2018, also Fool.com with their article: “Here’s Why T2 Biosystems, Inc. Rose Over 16% Today” published on June 01, 2018, Globenewswire.com published: “T2 Biosystems Reports Granting of Inducement Awards” on June 06, 2018. More interesting news about T2 Biosystems, Inc. (NASDAQ:TTOO) were released by: Seekingalpha.com and their article: “T2 Biosystems Still Has A Way To Go” published on May 24, 2018 as well as Seekingalpha.com‘s news article titled: “T2 Biosytems: The Story Is Just Beginning” with publication date: June 03, 2018.

T2 Biosystems, Inc. (NASDAQ:TTOO) Ratings Coverage

Among 5 analysts covering T2 Biosystems (NASDAQ:TTOO), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. T2 Biosystems has $1400 highest and $5.2 lowest target. $9.55’s average target is -0.31% below currents $9.58 stock price. T2 Biosystems had 10 analyst reports since January 25, 2018 according to SRatingsIntel. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by H.C. Wainwright on Monday, February 12. H.C. Wainwright maintained the shares of TTOO in report on Thursday, March 29 with “Buy” rating. On Thursday, January 25 the stock rating was maintained by H.C. Wainwright with “Buy”. The rating was maintained by H.C. Wainwright on Wednesday, May 30 with “Buy”. The rating was upgraded by Janney Capital on Wednesday, May 9 to “Buy”. The company was maintained on Wednesday, March 7 by Canaccord Genuity. The rating was upgraded by Leerink Swann to “Buy” on Friday, June 1. The firm earned “Buy” rating on Wednesday, May 9 by H.C. Wainwright. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) has “Buy” rating given on Wednesday, March 7 by H.C. Wainwright.

T2 Biosystems, Inc. (NASDAQ:TTOO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.